Anti-microRNA-378a enhances wound healing process by upregulating integrin beta-3 and vimentin

Molecular Therapy

Volumn 22, Issue 10, 2014, Pages 1839-1850

  Li, Haoran ^a,b   Chang, Leslie ^a,b   Du, William W ^a,b   Gupta, Shaan ^a,b   Khorshidi, Azam ^a,b   Sefton, Michael ^a,b   Yang, Burton B ^a,b  

^a Canada   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE MICRORNA 378A; ANTISENSE OLIGONUCLEOTIDE; BETA3 INTEGRIN; MICRORNA; MICRORNA 378A; NANOPARTICLE; UNCLASSIFIED DRUG; VIMENTIN; CD34 ANTIGEN; MIRN378 MICRORNA, HUMAN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; SINGLE DRUG DOSE; UPREGULATION; WOUND HEALING; ANIMAL; BINDING SITE; CELL LINE; CELL MOTION; CHEMISTRY; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ANIMALS; ANTIGENS, CD34; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN BETA3; MALE; MICE; MICE, TRANSGENIC; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGORIBONUCLEOTIDES, ANTISENSE; RNA INTERFERENCE; VIMENTIN; WOUND HEALING;

EID: 84926150299     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2014.115     Document Type: Article

References (38)

1. Banerjee, J and Sen, CK (2013). MicroRNAs in skin and wound healing. Methods Mol Biol 936: 343-356.
2. Roy, S and Sen, CK (2012). miRNA in wound inflammation and angiogenesis. Microcirculation 19: 224-232.
3. Lee, DY, Deng, Z, Wang, CH and Yang, BB (2007). MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 104: 20350-20355.
4. Rutnam, ZJ, Wight, TN and Yang, BB (2013). miRNAs regulate expression and function of extracellular matrix molecules. Matrix Biol 32: 74-85.
5. Lee, DY, Jeyapalan, Z, Fang, L, Yang, J, Zhang, Y, Yee, AY et al. (2010). Expression of versican 3'-untranslated region modulates endogenous microRNA functions. PLoS One 5: e13599.
6. Jeyapalan, Z, Deng, Z, Shatseva, T, Fang, L, He, C and Yang, BB (2011). Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res 39: 3026-3041.
7. Rutnam, ZJ, Du, WW, Yang, W, Yang, X and Yang, BB (2014). The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs. Nat Commun 5: 2914.
8. Yang, X, Rutnam, ZJ, Jiao, C, Wei, D, Xie, Y, Du, J et al. (2012). An anti-let-7 sponge decoys and decays endogenous let-7 functions. Cell Cycle 11: 3097-3108.
9. Ebert, MS, Neilson, JR and Sharp, PA (2007). MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4: 721-726.
10. Boutla, A, Delidakis, C and Tabler, M (2003). Developmental defects by antisensemediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nucleic Acids Res 31: 4973-4980.
11. Meister, G, Landthaler, M, Dorsett, Y and Tuschl, T (2004). Sequence-specific inhibition of microRNA-And siRNA-induced RNA silencing. RNA 10: 544-550.
12. Davis, S, Lollo, B, Freier, S and Esau, C (2006). Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res 34: 2294-2304.
13. Caré, A, Catalucci, D, Felicetti, F, Bonci, D, Addario, A, Gallo, P et al. (2007). MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618.
14. Deng, Z, Du, WW, Fang, L, Shan, SW, Qian, J, Lin, J et al. (2013). The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor. J Biol Chem 288: 319-331.
15. Kahai, S, Lee, SC, Lee, DY, Yang, J, Li, M, Wang, CH et al. (2009). MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS One 4: e7535.
16. Deng, Z, Yang, X, Fang, L, Rutnam, ZJ and Yang, BB (2013). Misprocessing and functional arrest of microRNAs by miR-Pirate: roles of miR-378 and miR-17. Biochem J 450: 375-386.
17. Li, H and Yang, BB (2013). Friend or foe: the role of microRNA in chemotherapy resistance. Acta Pharmacol Sin 34: 870-879.
18. Eckes, B, Colucci-Guyon, E, Smola, H, Nodder, S, Babinet, C, Krieg, T et al. (2000). Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci 113 (Pt 13): 2455-2462.
19. Shu, YY and Maibach, HI (2011). Estrogen and skin: therapeutic options. Am J Clin Dermatol 12: 297-311.
20. Speight, P, Nakano, H, Kelley, TJ, Hinz, B and Kapus, A (2013). Differential topical susceptibility to TGF in intact and injured regions of the epithelium: key role in myofibroblast transition. Mol Biol Cell 24: 3326-3336.
21. Green, H and Kehinde, O (1975). An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5: 19-27.
22. Mahabeleshwar, GH, Chen, J, Feng, W, Somanath, PR, Razorenova, OV and Byzova, TV (2008). Integrin affinity modulation in angiogenesis. Cell Cycle 7: 335-347.
23. De, S, Razorenova, O, McCabe, NP, O'Toole, T, Qin, J and Byzova, TV (2005). VEGFintegrin interplay controls tumor growth and vascularization. Proc Natl Acad Sci USA 102: 7589-7594.
24. Sakamoto, Y, Ogita, H, Komura, H and Takai, Y (2008). Involvement of nectin in inactivation of integrin alpha(v)beta(3) after the establishment of cell-cell adhesion. J Biol Chem 283: 496-505.
25. Krützfeldt, J, Rajewsky, N, Braich, R, Rajeev, KG, Tuschl, T, Manoharan, M et al. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
26. Babar, IA, Cheng, CJ, Booth, CJ, Liang, X, Weidhaas, JB, Saltzman, WM et al. (2012). Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci USA 109: E1695-E1704.
27. Rottiers, V and Näär, AM (2012). MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13: 239-250.
28. Biswas, S, Roy, S, Banerjee, J, Hussain, SR, Khanna, S, Meenakshisundaram, G et al. (2010). Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci USA 107: 6976-6981.
29. Hong, HJ, Jin, SE, Park, JS, Ahn, WS and Kim, CK (2008). Accelerated wound healing by smad3 antisense oligonucleotides-impregnated chitosan/alginate polyelectrolyte complex. Biomaterials 29: 4831-4837.
30. Moulin, V, Auger, FA, Garrel, D and Germain, L (2000). Role of wound healing myofibroblasts on re-epithelialization of human skin. Burns 26: 3-12.
31. Bavan, L, Midwood, K and Nanchahal, J (2011). MicroRNA epigenetics: a new avenue for wound healing research. BioDrugs 25: 27-41.
32. Philips, BJ, Marra, KG and Rubin, JP (2012). Adipose stem cell-based soft tissue regeneration. Expert Opin Biol Ther 12: 155-163.
33. Liu, F, Lv, Q, Du, WW, Li, H, Yang, X, Liu, D et al. (2013). Specificity of miR-378a-5p targeting rodent fibronectin. Biochim Biophys Acta 1833: 3272-3285.
34. Li, H and Yang, BB (2012). Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget 3: 1653-1668.
35. Fang, L, Du, WW, Yang, X, Chen, K, Ghanekar, A, Levy, G et al. (2013). Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J 27: 907-919.
36. Yang, X, Du, WW, Li, H, Liu, F, Khorshidi, A, Rutnam, ZJ et al. (2013). Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res 41: 9688-9704.
37. Rutnam, ZJ and Yang, BB (2012). The non-coding 3' UTR of CD44 induces metastasis by regulating extracellular matrix functions. J Cell Sci 125(Pt 8): 2075-2085.
38. Steinstraesser, L, Hirsch, T, Beller, J, Mittler, D, Sorkin, M, Pazdierny, G et al. (2007). Transient non-viral cutaneous gene delivery in burn wounds. J Gene Med 9: 949-955.